Apieron seeks $25M under new leadership
Apieron Inc. plans to score $25 million in its currently open fourth-round of funding to advance development and build up sales of an asthma monitoring device.
This round is the first of Holly McGarraugh’s brand new tenure as president and chief executive officer. She joined the Menlo Park, Calif.-based company in January as vice president for marketing. While the company is still busy hammering out term sheets with venture capital firms, McGarraugh says the round should close by the end of the year.
Apieron has had good luck in previous investment rounds, raising $37.6 million since 2003 from firms including Onset Ventures, Alliance Technology Ventures, Canaan Partners and Draper Fisher Jurvetson. The money brought in during its third round, amounting to $17 million, helped the company push its product through the Food and Drug Administration approval process in May.
Next Story: IBM’s Innovation Jam 2008 shows how far crowdsourcing has come
Previous Story: Entellium execs fudge the numbers, face fraud charges
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.